Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections

The published paper – Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections illustrates the highlights of the study and its results. Dr. Ashwin Porwal was an important part of the team who conducted research on this topic. He is among the first authors of this scientific paper published in the journal The New England Journal of Medicine.

In this research study, 63 patients with more than 90% patient compliance were involved. Those patients were classified in to wound infection, cellulitis and major cutaneous abscess.

Please follow and like us: